Morgan Stanley Sees 3 PhIII Trials for COVID Vaccines This Fall (MRNA) (AZN) (PFE)
Tweet Send to a Friend
Morgan Stanley analyst Matthew Harrison reiterated an Overweight rating on Moderna (NASDAQ: MRNA) and an Equalweight rating on Pfizer (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
